Josh Levine Names Three Biotech Game-Changers

The Life Sciences Report: You see micro-cap investing very much like venture capital (VC) investing. How so? Joshua Levine: From time to time I talk about micro-cap investing as a form of venture investing . . . → Read More: Josh Levine Names Three Biotech Game-Changers Similar posts: Michael Berry Applies His 10 Discovery Investing Factors to Biotech The Life Sciences Report: We know you as a natural... Applying the Venture Capital Model to Public Companies: Hugh Cleland The Life Sciences Report: In your letter to investors dated... Think Long Term and Win Big with Small Biotechs: Hugh Cleland The Life Sciences Report: Are your investors exclusively Canadians? Hugh...

The Life Sciences Report: You see micro-cap investing very much like venture capital (VC) investing. How so?

Joshua Levine: From time to time I talk about micro-cap investing as a form of venture investing for the public. We are not looking for a 25% gain. The micro-cap investor, like the venture investor, is looking for big multiple gains of three, five or 10 times over the life of the investment. There is a very big risk-reward factor for investors in micro caps, and the micro-cap investor should have the same long-term perspective that the venture capitalist … [visit site to read more]

Similar posts:
  1. Michael Berry Applies His 10 Discovery Investing Factors to Biotech The Life Sciences Report: We know you as a natural...
  2. Applying the Venture Capital Model to Public Companies: Hugh Cleland The Life Sciences Report: In your letter to investors dated...
  3. Think Long Term and Win Big with Small Biotechs: Hugh Cleland The Life Sciences Report: Are your investors exclusively Canadians? Hugh...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.